SCHEMBL7301899

SCHEMBL7301899

CCC(C(C)C(=O)NOC(C)(C)C)S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 13/20 0.49
MMP2 P08253 9/20 0.49
MMP3 P08254 8/20 0.49
PDE4A P27815 2/20 0.49
PDE4B Q07343 2/20 0.49
PDE4C Q08493 2/20 0.49
PDE4D Q08499 2/20 0.49
MMP13 P45452 9/20 0.49
MMP9 P14780 9/20 0.49
ADAM17 P78536 3/20 0.47
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
HSD17B10 Q99714 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KMT2A Q03164 1/20 0.41
MMP8 P22894 1/20 0.41
MMP12 P39900 1/20 0.41
MMP14 P50281 1/20 0.41
MMP16 P51512 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7306444 0.85 MMP1 (0.65) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL7305749 0.80 MMP13 (0.71) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL7309436 0.75 MMP1 (0.50) MMP1MMP2MMP3MMP13MMP9
SCHEMBL7311621 0.74 ALDH1A1 (0.44) ADAM17CA1CA2HSD17B10ALDH1A1
SCHEMBL7344510 0.72 SLC1A3 (0.56) MMP1MMP2MMP3MMP13MMP9
SCHEMBL7344506 0.72 SLC1A3 (0.56) MMP1MMP2MMP3MMP13MMP9
SCHEMBL7212138 0.70 MMP13 (0.54) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL30720709 0.69 MMP13 (0.56) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL7207037 0.69 MMP1 (0.55) MMP1MMP2MMP3PDE4APDE4B
SCHEMBL14636309 0.68 SLC1A3 (0.41) MMP1MMP2MMP3MMP13MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0780386-B1 Matrix metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2002-10-02 EP disclosed
US-5932595-A ANTIARTHRITIC AGENT; MULTIPLE SCLEROSIS; OSTEOPOROSIS; RESPIRATORY SYSTEM DISORDERS; SKIN DISORDERS; ANTIULCER AGENT SYNTEX (U.S.A.) INC. (US) 1999-08-03 US disclosed
EP-0780386-A1 Matrix metalloprotease inhibitors F. HOFFMANN-LA ROCHE AG (CH) 1997-06-25 EP disclosed